Patent ID: 8415342
Filing Date: 2013-04-09
Classification: A61K,A61P

Abstract:
1. A method for treating or controlling bacterial conjunctivitis in a human subject, the method comprising administering to said human subject a composition comprising besifloxacin at a concentration of 0.6% (weight by volume) at a frequency of two, three, or four times per day for 5-10 days in an amount effective for said treating or controlling, wherein said bacterial conjunctivitis is caused by a bacterium selected from the group consisting of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus warneri, Staphylococus hominis, Morganella morganii, Prevotella spp., and Fusobacterium against which an MIC 90 of gatifloxacin or moxifloxacin is at least 4 μg/mL.